John Westwater
Chief Financial Officer
Pharmaceutical sciences
Elastagen
Australia
Biography
John is our Chief Financial Officer and joined the Company in 2015. He has over thirteen years experience in the life science financial industry, eight years as a venture capital investor and remainder as an investment banking professional. Prior to joining Elastagen he was at Phase4 Ventures (formerly Nomura Phase4 Ventures), a global life science VC firm based in London. During this period he was actively involved with several investments both in the US and Europe: including Nabriva Therapeutics, Paratek Pharmaceuticals, Zosano Pharma and Acadia Pharmaceuticals.
Research Interest
Pharmaceutical sciences
